PMC:7340597 / 2841-3131 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"122","span":{"begin":158,"end":166},"obj":"Species"},{"id":"123","span":{"begin":274,"end":282},"obj":"Species"},{"id":"133","span":{"begin":18,"end":32},"obj":"Disease"},{"id":"134","span":{"begin":63,"end":76},"obj":"Disease"},{"id":"135","span":{"begin":106,"end":128},"obj":"Disease"},{"id":"136","span":{"begin":149,"end":157},"obj":"Disease"},{"id":"137","span":{"begin":201,"end":224},"obj":"Disease"},{"id":"138","span":{"begin":265,"end":273},"obj":"Disease"}],"attributes":[{"id":"A122","pred":"tao:has_database_id","subj":"122","obj":"Tax:9606"},{"id":"A123","pred":"tao:has_database_id","subj":"123","obj":"Tax:9606"},{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"MESH:D013923"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"MESH:D001228"},{"id":"A135","pred":"tao:has_database_id","subj":"135","obj":"MESH:D054556"},{"id":"A136","pred":"tao:has_database_id","subj":"136","obj":"MESH:C000657245"},{"id":"A137","pred":"tao:has_database_id","subj":"137","obj":"MESH:D055732"},{"id":"A138","pred":"tao:has_database_id","subj":"138","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" of this disease: thromboembolic complications and early onset aspergillosis. The cumulative incidence of venous thromboembolism reported was 49% in COVID-19 patients admitted to the ICU [8]. Presumed pulmonary aspergillosis may be present in as much as 19% of ICU COVID-19 patients [9]. Si"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T43","span":{"begin":63,"end":76},"obj":"Disease"},{"id":"T44","span":{"begin":106,"end":128},"obj":"Disease"},{"id":"T45","span":{"begin":149,"end":157},"obj":"Disease"},{"id":"T46","span":{"begin":211,"end":224},"obj":"Disease"},{"id":"T47","span":{"begin":265,"end":273},"obj":"Disease"}],"attributes":[{"id":"A43","pred":"mondo_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0005399"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" of this disease: thromboembolic complications and early onset aspergillosis. The cumulative incidence of venous thromboembolism reported was 49% in COVID-19 patients admitted to the ICU [8]. Presumed pulmonary aspergillosis may be present in as much as 19% of ICU COVID-19 patients [9]. Si"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":18,"end":32},"obj":"Phenotype"},{"id":"T10","span":{"begin":113,"end":128},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0001907"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0001907"}],"text":" of this disease: thromboembolic complications and early onset aspergillosis. The cumulative incidence of venous thromboembolism reported was 49% in COVID-19 patients admitted to the ICU [8]. Presumed pulmonary aspergillosis may be present in as much as 19% of ICU COVID-19 patients [9]. Si"}

{"project":"LitCovid-sentences","denotations":[{"id":"T27","span":{"begin":78,"end":191},"obj":"Sentence"},{"id":"T28","span":{"begin":192,"end":287},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" of this disease: thromboembolic complications and early onset aspergillosis. The cumulative incidence of venous thromboembolism reported was 49% in COVID-19 patients admitted to the ICU [8]. Presumed pulmonary aspergillosis may be present in as much as 19% of ICU COVID-19 patients [9]. Si"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T35","span":{"begin":18,"end":32},"obj":"GO:0007596"},{"id":"T36","span":{"begin":106,"end":112},"obj":"UBERON:0001638"},{"id":"T37","span":{"begin":113,"end":128},"obj":"GO:0007596"},{"id":"T38","span":{"begin":149,"end":157},"obj":"SP_7"},{"id":"T39","span":{"begin":201,"end":210},"obj":"UBERON:0002048"},{"id":"T40","span":{"begin":265,"end":273},"obj":"SP_7"},{"id":"T83979","span":{"begin":126,"end":141},"obj":"GO:0050817"},{"id":"T7331","span":{"begin":168,"end":175},"obj":"CHEBI:24505;CHEBI:24505"},{"id":"T34114","span":{"begin":273,"end":282},"obj":"UBERON:0002048"}],"text":" of this disease: thromboembolic complications and early onset aspergillosis. The cumulative incidence of venous thromboembolism reported was 49% in COVID-19 patients admitted to the ICU [8]. Presumed pulmonary aspergillosis may be present in as much as 19% of ICU COVID-19 patients [9]. Si"}

{"project":"2_test","denotations":[{"id":"32674001-32381264-58631470","span":{"begin":188,"end":189},"obj":"32381264"}],"text":" of this disease: thromboembolic complications and early onset aspergillosis. The cumulative incidence of venous thromboembolism reported was 49% in COVID-19 patients admitted to the ICU [8]. Presumed pulmonary aspergillosis may be present in as much as 19% of ICU COVID-19 patients [9]. Si"}